Literature DB >> 24493755

Targeting ion transport in cancer.

E Oosterwijk1, R J Gillies.   

Abstract

The metabolism of cancer cells differs substantially from normal cells, including ion transport. Although this phenomenon has been long recognized, ion transporters have not been viewed as suitable therapeutic targets. However, the acidic pH values present in tumours which are well outside of normal limits are now becoming recognized as an important therapeutic target. Carbonic anhydrase IX (CAIX) is fundamental to tumour pH regulation. CAIX is commonly expressed in cancer, but lowly expressed in normal tissues and that presents an attractive target. Here, we discuss the possibilities of exploiting the acidic, hypoxic tumour environment as possible target for therapy. Additionally, clinical experience with CAIX targeting in cancer patients is discussed.

Entities:  

Keywords:  carbonic anhydrase IX; clinical experience; targeting; translation; tumour acidity

Mesh:

Substances:

Year:  2014        PMID: 24493755      PMCID: PMC3917361          DOI: 10.1098/rstb.2013.0107

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  80 in total

Review 1.  The biology of cell locomotion within three-dimensional extracellular matrix.

Authors:  P Friedl; E B Bröcker
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

2.  Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250.

Authors:  K Grabmaier; J L Vissers; M C De Weijert; J C Oosterwijk-Wakka; A Van Bokhoven; R H Brakenhoff; E Noessner; P A Mulders; G Merkx; C G Figdor; G J Adema; E Oosterwijk
Journal:  Int J Cancer       Date:  2000-03-15       Impact factor: 7.396

Review 3.  The physiological environment in cancer vascularization, invasion and metastasis.

Authors:  Z M Bhujwalla; D Artemov; E Aboagye; E Ackerstaff; R J Gillies; K Natarajan; M Solaiyappan
Journal:  Novartis Found Symp       Date:  2001

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

Authors:  J Pastorek; S Pastoreková; I Callebaut; J P Mornon; V Zelník; R Opavský; M Zat'ovicová; S Liao; D Portetelle; E J Stanbridge
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

6.  Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents.

Authors:  Natarajan Raghunand; Brent P Mahoney; Robert J Gillies
Journal:  Biochem Pharmacol       Date:  2003-10-01       Impact factor: 5.858

Review 7.  Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target.

Authors:  Christian Potter; Adrian L Harris
Journal:  Cell Cycle       Date:  2004-02       Impact factor: 4.534

8.  Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.

Authors:  Karin Grabmaier; Mirjam C A de Weijert; Gerald W Verhaegh; Jack A Schalken; Egbert Oosterwijk
Journal:  Oncogene       Date:  2004-07-22       Impact factor: 9.867

9.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Cytostatic potential of novel agents that inhibit the regulation of intracellular pH.

Authors:  P Wong; H-W Kleemann; I F Tannock
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

View more
  6 in total

1.  Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?

Authors:  Alexandre Chigaev
Journal:  Front Pharmacol       Date:  2015-07-02       Impact factor: 5.810

Review 2.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 3.  Ion channels in cancer: future perspectives and clinical potential.

Authors:  Florian Lang; Christos Stournaras
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

4.  EpilepsyGene: a genetic resource for genes and mutations related to epilepsy.

Authors:  Xia Ran; Jinchen Li; Qianzhi Shao; Huiqian Chen; Zhongdong Lin; Zhong Sheng Sun; Jinyu Wu
Journal:  Nucleic Acids Res       Date:  2014-10-16       Impact factor: 19.160

5.  Cancer: fundamentals behind pH targeting and the double-edged approach.

Authors:  Tomas Koltai
Journal:  Onco Targets Ther       Date:  2016-10-17       Impact factor: 4.147

6.  Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.

Authors:  Yi-Ying Lee; Yu-Ching Wei; Yu-Feng Tian; Ding-Ping Sun; Ming-Jen Sheu; Ching-Chieh Yang; Li-Ching Lin; Chen-Yi Lin; Chung-Hsi Hsing; Wan-Shan Li; Chien-Feng Li; Pei-Ling Hsieh; Ching-Yih Lin
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.